Increase production capacity by optimizing maintenance frequencies

The Drug Substance (DS) reliability workstream has developed guidance enabling member companies to optimize their maintenance and calibration frequencies by assigning the correct ‘trigger’ for these activities. The guidance describes the various tools and processes available, as well as methods to implement change, illustrated by case studies. The Return on Investment (RoI) for optimization of maintenance frequencies is clear: direct reduction of maintenance man-hours and planned downtime, thus increasing plant availability. This translates to financial savings as well as increased production capacity.

The guidance document can be accessed here:

Currently, significant time and resource is expended on planned maintenance and calibration activities that add no value, do not increase asset reliability and can even have a detrimental affect to productivity by directly causing equipment failure. These frequencies aren’t driven by data or scientific basis and generally are assigned because historically ‘they have always been executed that way’. How often have you seen a planned maintenance (PM) or calibration task scheduled yearly as standard, and everyone from Engineering, QA, regulators to production are comfortable with that? However, the only reason for assigning a yearly frequency is because the earth has rotated around the sun once – there really is no more supporting data or science to it than that.

Vendors may recommend a specific frequency, but generally will ‘play it safe’ and may be led by the vendors’ driver to increase sales for change parts. – Remember, they have no understanding of the operational environment the equipment will be used in. Would you change the tyres on your car on a yearly frequency regardless of whether it had done 5,000 or 50,000 miles in that year? Or would you review data such as wear and tread depth before you invested in new tyres?

Intrusive maintenance activities can actually cause failures. How often have you come out of a shutdown and equipment has failed to start-up due to the routine maintenance that has taken place? Or an instrument has been damaged during a calibration routine? A less frequent intervention will reduce this risk.

The guidance outlines methods to assess equipment and put in place the right PM at the right time, using a data driven approach.

Why it’s important to implement and optimize your maintenance frequencies

As the case studies in the guidance demonstrate there are significant gains to be made by optimizing maintenance and calibration frequencies and the consequential reduction in labor hours – not just from the direct cost savings from a maintenance team’s perspective but to all stakeholders. The resulting increase in plant availability (both from planned shutdowns and unplanned downtime) is something that all areas of a biopharma organization will gain from, as it directly improves capacity to produce batches and thus impacts the bottom line.

So many organizations have not yet challenged their maintenance or calibration frequencies, it is ‘low hanging fruit’ that can be targeted to gain huge returns in terms of dollars but also product quality. By introducing the right task at the right time, a risk based approach reduces risk to equipment and thus product.

One case study particularly illustrates the use of statistical methods to analyse historical failure data and assign the correct frequency to calibration activities. It shows how one organization could reduce calibrations by over 50% across its operations, resulting in direct savings in the region of $1-$2m year on year.

What we are going to do as a reliability ‘COP’?

Although the reliability workstream has now transitioned to a Community of Practice (COP), work will not stop. A key focus of the COP will be to track implementation of this guidance and to support member companies by sharing case studies and lessons learnt to identify improvement opportunities.

What companies need to do?

Each company can make changes to calibration and maintenance routines and realize the benefits that are there to be gained.

L3s within the reliability COP will be connecting with key stakeholders in their organizations to begin implementation. Clearly, these stakeholders need to understand and endorse the changes that will be proposed (complete with a risk-based justification). Key for this is for senior leadership to provide clear support and guidance to implement changes.

If you are interested in learning more about this process, please reach out to your L3s in the reliability team.

Contact address

BioPhorum
The Gridiron Building
One Pancras Square
London
N1C 4AG

Newsletter subscribe

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.



© 2019 Biophorum Operations Group · All Rights Reserved

Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ

Company Number 06794795 · VAT Number GB298617544

Driving progress in Cell & Gene Therapy

Now with 19 member companies and 183 subject matter experts, the BioPhorum Cell & Gene Therapy (C>) Phorum has made great strides since its formation[...]

Read More
Join BioPhorum at BioProcess International events

We have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]

Read More
Cell and Gene Therapy Phorum accelerates progress

The BioPhorum Cell & Gene Therapy Phorum has made significant progress since its creation in 2018 – from building networks and sharing knowledge to endorsing[...]

Read More
The BioPhorum and USP collaborative journey to new standards

BioPhorum and United States Pharmacopeia (USP) share a common direction – to accelerate biopharma innovation, quality and progress through collaboration.

Read More
Perfecting balanced scorecards for CDMOs

Established in March 2017, the Development Group’s Development Outsourcing effort aims to share and build guidance that will help companies make the best decisions and[...]

Read More
Formulation team drive for more value

Since its start in 2013, the Formulation Point Share has been busy. Its latest article, An inter-company perspective on biopharmaceutical drug product robustness studies, was[...]

Read More
Join BioPhorum at BioProcess International events

We have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
Why leaders should go to where work is performed to learn about success, failure and risk
Read More
Hi-tech ambitions for Fill Finish

The Fill Finish Phorum has recently embarked on a series of exciting and ambitious initiatives, exploring new technologies and processes to enhance the efficiency and[...]

Read More
Companies poised to follow ARMM recommendations

The Advanced and Rapid Microbial Methods (ARMM) team set out a clear case for modernizing Environmental Monitoring (EM) in grade A settings: in summary bio-fluorescent[...]

Read More
How to achieve the ‘Goldilocks’ amount of environmental monitoring

Regulators require a risk-based approach to environmental monitoring (EM)… but they give no clear definition of what “risk-based” actually means. The aim of the Environmental[...]

Read More
The ‘how to’ guide to implementing Agile in GxP

The publication of the Guidance on the use of Agile in a GxP Environment document in 2017 was well received.It described how the use of[...]

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
Join BioPhorum at BioProcess International events

We have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]

Read More
Supply chain, forecasting and demand planning solutions gain momentum

The relationship between suppliers and manufacturers is one of the most crucial in biopharmaceutical manufacturing. This is especially the case when forecasting and supply planning.[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
Changing mindsets with a modular approach

Historically, manufacturers have used a ‘waterfall’ approach when designing and building their production facilities, sequentially resolving and specifying all aspects up front and in detail[...]

Read More
Join BioPhorum at BioProcess International events

We have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]

Read More
How do you bring technology roadmapping to life?

You use it to make change happen and that is exactly what the Phorum’s leaders did after the first edition of the Biomanufacturing Technology Roadmaps[...]

Read More
Slicing years off change implementation

As the first regulatory authority in Latin America to gain full membership of the International Council for Harmonization (ICH), the Brazilian Health Regulatory Agency (Anvisa)[...]

Read More
BioPhorum Regulatory Interaction: helping to open doors

To implement any change in the biopharmaceutical manufacturing industry it is important to engage with and collaborate with the regulators. Set up two years ago,[...]

Read More

IaaS Cloud webinar recording play back
Read More
New BPIT guidance to align cloud services to regulatory requirements
Read More
Data Integrity and Agile Webinars to support industry response to regulators
Read More
How to validate informatics in CPV programs

The BioPhorum Continued Process Verification (CPV) and Informatics team has published a paper to support a risk-based approach for the validation of informatics systems for[...]

Read More
Continued Process Verification delivering real saving in time and money

More than 50 per cent of biopharma products on the market now have Continued Process Verification (CPV) plans in place.  Thanks to the CPV white[...]

Read More
A roadmap for the implementation of continued process verification

This article provides a roadmap draws on the content of the CPV case study to provide a step-by-step guide in a more accessible form.

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
Digital plant maturity model webinar replay
Read More
Digital Plant Maturity Model workstream to host webinar
Read More
New guidance available on Forecasting and Demand Planning to streamline supply chain performance
Read More
Host cell proteins poster

This poster presented at the BEBPA Conference, San Francisco builds and consolidates the information currently available in the industry for assessing process risk from Host[...]

Read More
Host cell protein risk assessment, an industry approach

Host cell protein (HCP) constitutes a significant class of process-related impurities in biological drugs.

Read More
BEBPA risk assessment workshop
Read More
New toolkit to accelerate single-use design and specification

The single-use user requirements toolkit is now live and available for free download on the BioPhorum website  The toolkit streamlines the design and specification process[...]

Read More